Flagship Private Wealth’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-15
Closed -$3.09K 100
2021
Q2
$3.09K Hold
15
﹤0.01% 300
2021
Q1
$1.73K Sell
15
-26
-63% -$2.76K ﹤0.01% 288
2020
Q4
$4.34K Buy
+41
New +$4.03K ﹤0.01% 268

Other funds holding BNTX

Flagship Private Wealth's BNTX Position: Q3 2021 in Review

Flagship Private Wealth sold out of BioNTech (BNTX) in Q3 2021, closing a stake of 15 shares — an estimated $3.09K sold.

Flagship Private Wealth first reported a position in BNTX in Q4 2020 and held it in 3 quarters. The position peaked at $4.34K in Q4 2020. 335 funds tracked by Wall St. Rank hold BNTX as of Q3 2021.

  • Flagship Private Wealth reported no remaining BioNTech position as of Q3 2021 after selling out during the quarter.
  • Flagship Private Wealth sold 15 BioNTech shares in Q3 2021, an estimated $3.09K.
  • Flagship Private Wealth first reported a position in BioNTech in Q4 2020 and held it in 3 quarters.
  • Flagship Private Wealth's BioNTech position peaked at $4.34K in Q4 2020.
  • 335 funds tracked by Wall St. Rank held BioNTech as of Q3 2021.

Based on Flagship Private Wealth's 13F filing for Q3 2021, filed 20 Oct 2021.